As of Thursday afternoon, there are 10,985 confirmed cases of COVID-19 in the United States and zero FDA-approved drugs to treat the infection.
While DARPA works on short-term “firebreak” countermeasures and computational scientists track sources of new cases of the virus, a host of drug discovery companies are putting their AI technologies to work predicting which existing drugs, or brand-new drug-like molecules, could treat the virus.
Comments are closed.